Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online October 15, 2022.
Article Versions
- You are currently viewing a Latest version of this article (October 15, 2022 - 04:05).
- latest version (November 15, 2022 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2022 The Journal of Rheumatology
Author Information
- Chong Seng Edwin Lim,
- Louise Hamilton,
- Samantha Bee Lian Low,
- Andoni Toms,
- Alexander Macgregor and
- Karl Gaffney
-
Funding: AbbVie (The grant was for an investigator-initiated study).
Authors, Role & Affiliations: C.S.E.L, Lim, Consultant Rheumatologist, MBBS; L.H, Hamilton, Consultant Rheumatologist, MD; L.L, Low, Consultant Radiologist, MBBS; A.T, Toms, Consultant Radiologist; A.M. Macgregor, Consultant Rheumatologist; K.G. Gaffney, Consultant Rheumatologist, MB BCh BAO (Hons).
Rheumatology Department, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, United Kingdom; Radiology Department, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, United Kingdom.
Conflict of Interest: CL reports grants from AbbVie, during the conduct of the study. KG reports grants and personal fees from AbbVie, grants and personal fees from Eli Lilly, grants and personal fees from Novartis, grants and personal fees from UCB Pharma, grants from Gilead, during and outside the conduct of the study. LH, SL, AT, AM had nothing to disclose.
Corresponding Author: Dr Chong Seng Edwin Lim, Norfolk and Norwich University Hospitals NHS Foundation Trust, Rheumatology Department, Norfolk & Norwich University Hospital, Colney Lane, Norwich, United Kingdom, NR4 7UY Primary Email: edwin.lim@nnuh.nhs.uk, Alternate Email: ecslim@gmail.com.
Statement of ethics and consent: This study was conducted in accordance with the Declaration of Helsinki and was approved by the local ethics committee (252117 19/EE/0125). All participants gave written informed consent before study inclusion.